Hacker News new | past | comments | ask | show | jobs | submit login

There's a couple clinical trials with various variations of young blood or blood plasma being given to Alzheimer's patients. Should be interesting to see how that goes.



Did Peter Theil fund this research?


Not sure who's funding what

Most recent one I saw is this one that I think is funded by the Norwegian government

https://bmjopen.bmj.com/content/12/9/e056964

Then there's startups like Alkahest https://www.alkahest.com/pipeline/akst-grf6019/

Clinical trials of sorts has been going on since at least 2017 https://www.nature.com/articles/nature.2017.22930


It was a joke as Peter Theil has been jokingly called a vampire because he gets blood transfusions from young people in an effort to maintain his youth.

That being said, thanks for the links. I read them all.

Here is the results of the Phase II from Alkahest. Not a game changer thus far. https://www.alzforum.org/therapeutics/grf6019




Consider applying for YC's Spring batch! Applications are open till Feb 11.

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: